These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 26458129

  • 1. Bisphosphonate-Mediated Oral Ulcers: A Rare Differential Diagnosis of Erosive Oral Lesions.
    Lengfeld J, Buder-Bakhaya K, Goebeler M, Wobser M.
    Dermatology; 2016; 232(1):117-21. PubMed ID: 26458129
    [Abstract] [Full Text] [Related]

  • 2. Pharmacovigilance of oral bisphosphonates: adverse effects manifesting in the soft tissue of the oral cavity.
    Kharazmi M, Persson U, Warfvinge G.
    J Oral Maxillofac Surg; 2012 Dec; 70(12):2793-7. PubMed ID: 22609135
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharyngolaryngeal ulcers associated with the improper use of alendronate.
    Sakaida H, Yuasa H, Fukutome K, Takeuchi K.
    Auris Nasus Larynx; 2017 Dec; 44(6):762-765. PubMed ID: 27956102
    [Abstract] [Full Text] [Related]

  • 5. Oral ulcer associated with alendronate: a case report.
    Kharazmi M, Sjöqvist K, Rizk M, Warfvinge G.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):e11-3. PubMed ID: 20674418
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Severe oral ulcerations induced by alendronate.
    Demerjian N, Bolla G, Spreux A.
    Clin Rheumatol; 1999 Dec; 18(4):349-50. PubMed ID: 10468180
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bisphosphonates and oral pathology I. General and preventive aspects.
    Ponte Fernández N, Estefania Fresco R, Aguirre Urizar JM.
    Med Oral Patol Oral Cir Bucal; 2006 Aug 01; 11(5):E396-400. PubMed ID: 16878067
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adverse cutaneous drug reaction to alendronate.
    Brinkmeier T, Kügler K, Lepoittevin JP, Frosch PJ.
    Contact Dermatitis; 2007 Aug 01; 57(2):123-5. PubMed ID: 17627657
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multiple oral ulcers caused by incorrect use of oral bisphosphonate in a patient with dementia: A case report.
    Eguchi T, Basugi A, Kanai I, Miyata Y, Hamada Y.
    Gerodontology; 2019 Mar 01; 36(1):82-84. PubMed ID: 30461047
    [Abstract] [Full Text] [Related]

  • 20. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
    Adachi JD, Faraawi RY, O'Mahony MF, Nayar A, Massaad R, Evans JK, Yacik C.
    Clin Ther; 2009 Aug 01; 31(8):1747-53. PubMed ID: 19808133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.